Research Led by Johns Hopkins Medicine Shows Injectable Drug for Asthma and Allergies Could Reduce…
A study led by Johns Hopkins Children’s Center shows omalizumab — an injectable, Food and Drug Administration (FDA)-approved medication for treating asthma and other allergic conditions — substantially reduced potentially life-threatening…